Full text is available at the source.
Abstract
GLP-1 medications may be associated with a new form of weight stigma that goes beyond body size.
- Moral narratives around weight management often emphasize discipline and personal responsibility, framing GLP-1-assisted weight loss as a 'shortcut.'
- These perceptions reflect broader societal attitudes that stigmatize weight management approaches that utilize medications.
- GLP-1-related stigma encompasses judgments about the legitimacy and moral worthiness of using pharmacologic treatments for weight loss.
- This compounded stigma could lead to increased negative health impacts and hinder engagement with GLP-1 treatments.
- Investigating the differences between weight-based stigma and GLP-1-related stigma may enhance understanding and support for individuals with obesity.
Simplified